USM Fund Invests in KaloCyte

KaloCyte, Inc., http://kalocyte.com, a preclinical-stage healthcare biotechnology company has developed ErythroMer™, a synthetic, bio-inspired red blood cell substitute for use when stored red blood cells are not available. The company received a $300,000 investment from the University System of Maryland Momentum Fund (USM) https://www.momentum.usmd.edu, as part of a $750 K to 1 Million target funding with more than $600K raised to date. (more…)